A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
BackgroundPPARα and cyclooxygenase (COX)-2 are overexpressed in certain types of cancer. Thus, developing a dual inhibitor that targets both could be more effective as an anticancer agent than single inhibitors. We have previously shown that an analog of the bezafibrate named AA520 is a PPARα antago...
Saved in:
Main Authors: | Alessandra Ammazzalorso (Author), Stefania Tacconelli (Author), Annalisa Contursi (Author), Ulrika Hofling (Author), Carmen Cerchia (Author), Sara Di Berardino (Author), Alessandra De Michele (Author), Rosa Amoroso (Author), Antonio Lavecchia (Author), Paola Patrignani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro
by: Ulrika Hofling, et al.
Published: (2022) -
The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing
by: Paola Patrignani, et al.
Published: (2024) -
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action
by: Paola Patrignani, et al.
Published: (2024) -
Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
by: Patrizia Ballerini, et al.
Published: (2022) -
Grand challenges in pharmacotherapy of inflammation for the first decades of the 21st century
by: Paola Patrignani, et al.
Published: (2010)